NCDRC

NCDRC

RP/41/2017

RELIGARE HEALTH INSURANCE COMPANY LIMITED - Complainant(s)

Versus

AYUSH GUPTA - Opp.Party(s)

M/S. AVA LAW ASSOCIATES LLP

18 Sep 2017

ORDER

NATIONAL CONSUMER DISPUTES REDRESSAL COMMISSION
NEW DELHI
 
REVISION PETITION NO. 41 OF 2017
 
(Against the Order dated 19/09/2016 in Appeal No. 1237/2015 of the State Commission Punjab)
1. RELIGARE HEALTH INSURANCE COMPANY LIMITED
GYS GLOBAL PLOT NO. A, A4,A5, SECTOR 125 NOIDA-201301
GAUTAM BUDH NAGAR
UTTAR PRADESH
...........Petitioner(s)
Versus 
1. AYUSH GUPTA
THROUGH HIS MOTHER, SMT. VEENU NEXT FRIEND AND LEGAL GUARDIAN, R/O. NEW BUS STAND, NEAR SABZI MANDI, DHARIWAL, TEHSIL AND
DISTRICT-GURDASPUR
PUNJAB
...........Respondent(s)

BEFORE: 
 HON'BLE MR. JUSTICE D.K. JAIN,PRESIDENT
 HON'BLE MRS. M. SHREESHA,MEMBER

For the Petitioner :
Mr.Amit Tyagi, Advocate
For the Respondent :
Ms.Aditi Sharma, Advocate

Dated : 18 Sep 2017
ORDER

O R D E R (ORAL)

 

        Challenge in this Revision Petition, by Religare Health Insurance Co. Ltd. (for short “the Insurance Company”), the sole Opposite Party in the Complaint, is to the order dated 19.9.2016, passed by the State Consumer Disputes Redressal Commission, Punjab (for short “the State Commission”), in FA/1237/2015.  By the impugned order, the State Commission has over-turned the order dated 21.9.2015, passed by the District Consumer Disputes Redressal Forum, Gurdaspur (for short “the District Forum”) in Complaint No.108/2015.  On re-appraisal of the material on record, the State Commission has come to the conclusion that there was deficiency in service on the part of the Insurance Company in not reimbursing a sum of ₹1,50,934/-, the amount actually expended by the Complainant, the Respondent herein, for the surgery undergone by him for Left frontoparietal flap craniotomy and removal of large tumor on 04.9.14.  Thus, allowing the Complaint, the State Commission has directed the Insurance Company to pay to the Complainant a sum of ₹1,59,934/- along with interest @ 9% p.a. from the date of repudiation till realization; a sum of ₹20,000/- as compensation and ₹11,000/- as litigation expenses.

2.     The factum of the Complainant having undergone the afore-noted neurosurgery not being in dispute, the short question for consideration is whether or not the said claim falls within the ambit of the Exclusion Clause (4) in the terms and conditions of the Health Insurance cover, obtained by the Complainant ?

3.     Having heard learned Counsel for the parties and perused the documents on record, including the said Clause in the Policy; the Discharge Summary dated 8.9.2014; Lab Reports dated 10.9.2014 and 23.9.2014, we are of the opinion that the Revision Petition is bereft of any merit.

4.     For the sake of ready reference, the relevant Exclusion Clause is extracted below :

        “Specific waiting period

  1. Any Claim for or arising out of any of the following Illnesses or

    Surgical Procedures shall not be admissible during the first 24 (twenty four) consecutive months of coverage of the Insured Person by the Company from the first Policy Period Start Date :

     

    …………………………………

    …………………………………

     

    x.       Internal tumors, skin tumors, cysts, nodules, polyps including breast lumps (each of any kind) unless malignant.”

     

     

    5.     The stand of the Insurance Company is that since the claim made by the insured was within the cooling off period of 24 months and the tumor was not malignant, it was not liable to reimburse the afore-stated amount, in view of the afore-extracted Exclusion Clause.  According to the Insurance Company the onus was on the Complainant to prove that the tumor was malignant, which it failed to discharge.

    6.     It appears from the record, in particular, the Pathology Report dated 10.9.2014, that while recording the preliminary diagnosis, certain further investigations were advised.  Perhaps, on the advice, further laboratory tests were got conducted on 12.9.2014.  In the report dated 23.9.2014, the diagnosis was as under :

                     “Morphological features favour Neurocytoma, Extraventricular,

    WHO Grade II.”

     

     

    7.     Though in the said report, there was no specific finding to the effect that the sample was malignant but it was opined that Morphological features favoured Neurocytoma, a clear indicator in favour of malignancy.  At the same time, there is no clear finding that it was benign.  At this juncture, we may note that now at this stage, an attempt has been made by the Insurance Company to place on record a report dated 22.12.2016 by an Expert, opining that according to the documents placed before him, Hispopathology Report is in favour of benign lesion.   We fail to understand why such report could not be obtained by the Insurance Company before repudiating the claim or before filing its Written Version in opposition.  Apart from the fact that under our limited Revisional jurisdiction under Section 21(b) of the Consumer Protection Act, 1986 (for short “the Act”), no additional evidence can be permitted, even otherwise the said Report does not advance the case of the Insurance Company, in as much as the Report is based on the earlier reports placed before him by the Insurance Company in December 2016, for the surgery performed in September 2014, and not on the said Expert’s own clinical correlation of these Reports with the slides, etc.  Hence, the said report cannot be taken into consideration for deciding the question formulated above.

    8.     In that view of the matter, and in the light of the afore-noted evidence on record, we are of the opinion that the State Commission has not committed any material irregularity or illegality in coming to the afore-noted conclusion.  As a matter of fact, we are pained to note that all out efforts are being made by the Insurance Company to defend its decision in a case involving a petty claim of ₹1,50,934/-, when the actual surgery is not in dispute, with no substantial question of law of precedential value.

    9.     Having arrived at the afore-noted conclusion, the next question for consideration is whether the State Commission was justified in awarding in addition to the afore-noted compensation interest, on the amount actually expended by the insured on the afore-noted procedure.  Regard being had to the fact that the procedure was performed only in the year 2014, we are of the view that the award of interest on the aforesaid amount, spent by the Complainant is not warranted.

    10.   Consequently, the Revision Petition is partly allowed to the extent indicated above with a direction to the Insurance Company to remit directly to the Complainant a sum of ₹1,50,934/- along with the afore-stated amount of compensation and the litigation expenses, by means of a Demand Draft in his favour, within four weeks from the date of receipt of a copy of this order, failing which the said amount shall carry interest @ 9% p.a., from the date of filing of the Complaint till realization.  It would be open to the Insurance Company to withdraw the amount deposited in this Commission in terms of order dated 9.2.2017, along with accrued interest, if any.

    11.   The Revision Petition stands disposed of in the above terms with no order as to further costs.

 
......................J
D.K. JAIN
PRESIDENT
......................
M. SHREESHA
MEMBER

Consumer Court Lawyer

Best Law Firm for all your Consumer Court related cases.

Bhanu Pratap

Featured Recomended
Highly recommended!
5.0 (615)

Bhanu Pratap

Featured Recomended
Highly recommended!

Experties

Consumer Court | Cheque Bounce | Civil Cases | Criminal Cases | Matrimonial Disputes

Phone Number

7982270319

Dedicated team of best lawyers for all your legal queries. Our lawyers can help you for you Consumer Court related cases at very affordable fee.